ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260219.1	Ponatinib	Stomach adenocarcinoma	0.040813264	Sensitive
ENSG00000260219.1	Ponatinib	Colon adenocarcinoma	0.034414546	Resistant